Skip to content

LSD: all studies

Page 81 of 282: studies 801 to 810 of 2,815, newest first. Back to the LSD overview

Research

Lysergic Acid Diethylamide: Effects on the Developing Mouse Lens

Science May 2, 1969 J. K. Hanaway 28 citations

High doses (5 × 10- 6 gram) of LSD-25 given to Swiss-Webster females on gestation days 6, 7, 8, or 9 caused a high incidence of anterior subcapsular lens abnormalities. Accompanying this, the lens epithelium was often hyperplastic, and the lens bow was widened posteriorly in a fashion similar to cataracts induced by x-radiation. Confirmation of this effect of LSD-25 was obtained by a...

A Controlled Comparison of Lysergic Acid Diethylamide (LSD) and Dextroamphetamine in Alcoholics

American Journal of Psychiatry April 1, 1969 Leo E. Hollister, Jack Shelton, George Krieger 104 citations

Seventy-two alcoholic patients were admitted to a controlled comparison of LSD and dextroamphetamine as treatments. In the context of little associated psychotherapeutic intervention, LSD produced slightly better results early, but after six months the results were alike for both treatment groups. Controlled studies of such treatments are not only possible but mandatory, the authors conclude,...

DOI: 10.1176/ajp.125.10.1352 (opens in new tab) Lysergic acid diethylamide Dextroamphetamine Context archaeology Psychotherapist +1

An Evaluation of Aversion and LSD Therapy in the Treatment of Alcoholism

Canadian Psychiatric Association Journal February 1, 1969 C. G. Costello 5 citations

L'auteur passe en revue les études que l'on a faites sur l'emploi des stimulus en-gendrant la répugnance, ou de la diéthylamide de l'acide lysergique dans le traitement de l'alcoolisme. Ces stimulus étaient l'apomorphine, l'émétine, la scoline et le choc électrique. Rien n'indique à l'évidence que ces méthodes sont plus efficaces que les autres, non excitantes, pour traiter les alcooliques....

Lysergic acid diethylamide: Role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine)

Science 1969 Robert C. Lin, S. H. Ngai, E. Costa 69 citations

Injections of D-lysergic acid diethylamide decrease the turnover rate of 5-hydroxytryptamine of rat brain, as measured from the conversion of (14)C-tryptophan into (14)C-5-hydroxytryptamine. The 2-bromolysergic acid diethylamide given in doses fivefold greater than those of lysergic acid diethylamide fails to change the rate of (14)C-tryptophan conversion into (14)C-5-hydroxytryptamine. The...

Cytogenetic Effects of LSD 25 Therapy in Man

JAMA December 2, 1968 David A. Hungerford 40 citations

Chromosomes have been studied in leukocytes cultured from patients undergoing experimental therapy with lysergic acid diethylamide (LSD 25). Aberration frequencies prior to therapy were established for three of the four patients; these were comparable to frequencies in control subjects. Following each of three doses given intravenously (usually 200μg per dose), each patient's chromosomes were...

Lysergic Acid Diethylamide: Review and Collaborative Study

Journal of AOAC International November 1, 1968 James Look

Abstract A method for identification and determination of lysergic acid diethylamide (LSD) was studied collaboratively by 11 collaborators on three samples prepared by the Associate Referee. The presumptive test is a valuable tool for rapid preliminary examination. Racemization of the LSD adds further to its identification by paper chromatography. Assay recovery, based on Sandoz LSD-25...

LSD Research: The Impact of Lay Publicity

American Journal of Psychiatry November 1, 1968 Charles Clay Dahlberg, Ruth Mechaneck, Stanley Feldstein 25 citations

An inquiry was sent to 29 investigators conducting research involving the use of LSD or other hallucinogens, in an effort to determine what effects publicity about LSD may have had upon their research. Nineteen of the investigators reported that the publicity had negatively affected the recruitment of "appropriate" subjects, the attitudes of already participating subjects, the behavior of...

LSD: 1967

The British Journal of Psychiatry October 1, 1968 Glin Bennet

It is twenty years since the appearance of Stoll's paper: “Lysergic acid diethylamide, a hallucinatory agent of the ergot group” (23). In this he sought to reproduce in a group of subjects Hofmann's personal experiences of the drug, and so set the LSD snowball on its way. Some 1,500 papers must by now have been gathered to it; they deal with a greater range of uses than has been thought of for...

Lysergic Acid Diethylamide (LSD) in the Treatment of Alcoholism.

Archives of General Psychiatry October 1, 1968 Charles Clay Dahlberg 9 citations

The history of the use of LSD in medicine follows the usual pattern for a new drug: first, speculation on its use and mechanisms following preliminary browsing research; second, exaggerated claims about its value; and third, carefully controlled trials. This book is the first in what will undoubtedly be a long list of reports on the latter category. It is important for its virtues as well as...

Acute Leukemia With Ph1-Like Chromosome in an LSD User

JAMA September 9, 1968 Lionel Grossbard 23 citations

Acute leukemia occurred in a user of several hallucinogenic drugs (lysergic acid diethylamide [LSD], mescaline, marihuana, and amphetamines). The leukemic leukocytes of the patient contained a Ph1-like chromosome; lymphocytes transformed with phytohemagglutinin did not show chromosome breaks. A Ph1-like chromosome has only rarely been reported in either acute leukemia or in cultured lymphocytes...